Abstract Details
| Kevin A. Kerber, MD (Ohio State University Department of Neurology) | Dr. Kerber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Âé¶¹´«Ã½Ó³». The institution of Dr. Kerber has received research support from National Institutes of Health. The institution of Dr. Kerber has received research support from Genentech, Inc . Dr. Kerber has received publishing royalties from a publication relating to health care. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| A. Mark Fendrick | No disclosure on file |
| Lewis B. Morgenstern, MD, FÂé¶¹´«Ã½Ó³» (University of Michigan) | No disclosure on file |
| Nuria Carrillo, MD | Dr. Carrillo has received personal compensation for serving as an employee of Dianthus Therapeutics. Dr. Carrillo has or had stock in Dianthus Therapeutics.Dr. Carrillo has or had stock in Moderna Therapeutics. |